Get startedLog in
    Picture of Tetra Bio Pharma logo

    TBPMQ — Tetra Bio Pharma Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Tetra Bio Pharma, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.

    2017
    November 30th
    R2018
    November 30th
    R2019
    November 30th
    2020
    November 30th
    2021
    November 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Total Revenue00000
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Operating Interest Expense / Income
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses6.687.8413.120.950.6
    Operating Profit-6.68-7.84-13.1-20.9-50.6
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-6.7-7.84-13.1-21.2-52.2
    Net Income After Taxes-6.7-7.84-13.1-21.2-52.2
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income-6.23-7.57-15.3-26.5-52.2
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-6.23-7.57-15.3-26.5-52.2
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.054-0.079-0.069-0.08-0.062